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Though several studies on toxic effect of aspartame metabolite have been studied, there are scanty data
on whether aspartame exposure administration could release formate, a methanol metabolite thereby
inducing oxidative stress and neurodegeneration in brain discrete region. To mimic the human methanol
metabolism, the methotrexate (MTX) treated folate deﬁcient rats were used. Aspartame was adminis-
tered orally to the MTX treated animals and was studied along with controls and MTX treated controls.
Oral intubations of FDA approved 40 mg/kg b.wt aspartame were given daily for 90 days. The locoemotor
activity and emotionality behavior in the aspartame treated animals showed a marked increase in the
immobilization, fecal bolus with a marked decrease in ambulation, rearing, grooming. The anxiety
behavior in the aspartame treated animals showed a marked decrease in percentage of open arm entry,
percentage of time spent in open arm and number of head dips. It is appropriate to point out, formal-
dehyde and formate could have led to an increased formation of free radical in the aspartame treated
animals resulting in altered neurobehavioral changes owing to neuronal oxidative damage. Aspartame
induced ROS may be also linked to increased neuronal apoptosis. In this study the aspartame treated
animals showed an up regulation in the apoptotic gene expression along with protein expression in the
respective brain region indicating the enhancement of neuronal cell death. This study intends to
corroborate that chronic aspartame consumption can alter the behavior and neurodegeneration in brain
discrete regions.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
A commonly used low calorie artiﬁcial sweetener Aspartame, (L-
aspartyl-L-phenylalanine methyl ester) discovered in the year 1965
by James Schlatter of the G.D. Searle Company. The increased
market of dietary products and the development of new synthetic
sweetening compounds have not been sufﬁciently explored. Thus,
to verify the risks and beneﬁts of a substance present in our day-by-
day use like aspartame, leads us to worry about the actions of its
metabolites (aspartic acid, phenylalanine and methanol) to our
organism [1]. Even after the commercial approval of aspartame by
the FDA from the year 1981 [2] 40% of all complaints issued to the
FDA have been concerning adverse reactions after consumption of
aspartame [3] and since then it has caught the attention of many
researchers. Upon ingestion aspartame molecule is metabolizedSheeladevi).
Inc. This is an open access article uinto three metabolites namely 50% is phenylalanine, 40% is aspartic
acid, and 10% is methanol. The ﬁrst two are known as amino acid
isolates. It has been reported that consumption of aspartame could
cause neurological and behavioural disturbances in sensitive in-
dividuals [4]. Large doses of both aspartame as well as these indi-
vidual metabolites have been tested in humans and other animals
producing a controversial report. It has been reported that not only
the metabolites of methanol but methanol per se as well is toxic to
the brain [5]. The primary metabolic fate of methanol is the direct
oxidation to formaldehyde and then into formate. The toxic effects
of methanol in humans are due to the accumulation of its metab-
olite formate [6]. Relatively small amount of aspartame can
signiﬁcantly increase methanol levels [7], being that 10% of this
metabolism results in methanol, which is oxidized to formaldehyde
and formate in many tissues. Several studies on laboratory animals
have beenmade to verify aspartame's toxicity. Recently, a very large
experiment conﬁrmed that it is a multipotential carcinogenic agent
when given at a daily dose of 20 mg/kg body weight, an amount
well below the acceptable daily dose of 40 mg/kg body weight [8].nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The rodents do not develop metabolic acidosis during methanol
poisoning, owing to their high liver folate content and in order to
create similar results in human beings only folate deﬁcient rodents
are required to accumulate formate in order to develop acidosis
[10]. Hence, in this study in order to mimic the human situation, a
folate deﬁciency status is induced by administering MTX. Relatively
small amount of aspartame can signiﬁcantly increase methanol
levels [11].Methanol is being increasingly recognized as a substance
that damages the liver cells where it is oxidized to formaldehyde
and latter to formate [12]. Based on the literature study Kruse [13]
suggested that among the metabolites, methanol is a toxicant that
causes systemic toxicity. Parthasarathy et al. [11], reported that
methanol is primarily metabolized to formaldehyde and then to
formate, accompanied by the formation of superoxide anion and
hydrogen peroxide. Ashok et al. [14], have also reported that
chronic methanol exposure, which is a byproduct of aspartame,
may be responsible for the alteration observed in the free-radical-
scavenging system. Of all the organs in the body, the CNS is rich in
oxygen which exceeds its share of oxidative abuse due to free
radicals. This is associated with the abundance of redox active
transition metal ions and the virtual decease of antioxidant defense
system [15], the effect of oxidative modiﬁcation by reactive oxygen
species (ROS) on neuronal phospholipids, DNA, and proteins has
been implicated in the genesis of several neurodegenerative dis-
orders [16]. Potts et al. [17], showed that the administration of
aspartame as 9% of the diet for 13 weeks could alter learning
behavior in rats. Ashok et al., reported that methanol released by
aspartame has an effect in the brainwith an observed change in the
locomotor and anxiety level [18].
Recent studies on aspartame have been carried out to under-
stand the mechanisms of neurotoxicity [19,20]. The apoptotic
process is also affected by many other signaling pathways, espe-
cially activation via ROS in TNF- a-mediated JNK c-Jun N-terminal
kinases (JNK) (stress activated protein kinases) which has been
consistently demonstrated in various cellular systems [21]. JNK3 is
expressed predominantly in neurons but also in cardiac smooth
muscle and testes, which has 2 isoforms. Several different but
coexisting mechanisms guarantee the speciﬁcity of JNK in signal
transduction [22]. It is important to emphasize that in some in-
stances of neuronal injury, sustained c-Jun induction/activation
does not necessarily lead to death [23]. JNK activation in a primary
role from where it may induce expression of Fas or TNF-a [24] to
commit cells to apoptosis. JNK3 is predominately expressed in the
brain and is most consistently associated with neuronal death.
The Fas/FasL system transmits apoptotic signals from the sur-
rounding environment into the cell. Fas contain a single trans-
membrane domain and belong to the tumor necrosis factor (TNF)/
nerve growth factor family [25]. FasL contains a single trans-
membrane domain and is also a member of the same TNF family
[26]. A soluble formof FasL has beendescribed, but appears tobe less
capable of inducing apoptosis,when comparedwith the bound form
[27]. The binding of FasL with Fas initiates receptor oligomerization,
which recruits Fas-associated death domain (FADD) [28]. FADD
binds procaspase-8 and permits activation of caspase-8 through
self-cleavage [29]. Caspase-8 activates the effector caspases, which
commits the cell to the orderly process of apoptosis [30]. A transient
andmodest JNK activationmediates cell survival via NF-kB- induced
apoptotic gene expression, whereas a prolonged and robust JNK
activation is associated with cell apoptosis via ASK1 signaling [31].
This study is designed to determine whether the chronic oral
administration of aspartame (40 mg/kg) can release methanol as a
by-product after its metabolism and the effect of aspartame on re-
ceptor mediated Fas pathway on neuronal apoptosis in the brain
regions and its role in anxiety and emotional behavior.2. Materials and methods
2.1. Animals
Wistar strain male albino rats (200e220 g) were maintained
under standard laboratory conditions with water and food. For the
folate-deﬁcient group, folate-deﬁcient diet was provided for 45
days prior to the experiment and Methotrexate (MTX) was
administered for a week before the oral intubation of aspartame.
The folate deﬁciency was conﬁrmed by monitoring the FIGLU level
in the urine, after this conﬁrmation the aspartame oral intubation
was started. The animals were handled according to the principles
of laboratory care framed by the committee for the purpose of
Control and Supervision of Experiments on Animals (CPCSEA),
Government of India. Prior to the experimentation, proper approval
was obtained from the Institutional Animal Ethical Committee (No:
01/032/2010/Aug-11).
2.2. Chemicals
Aspartame and Methotrexate were purchased from Sigma
aldrich, St. Louis, MO, USA. Secondary antibodywas purchased from
Merck, Bangalore, the primary antibody was purchased from Bio-
vision, Pierce USA. Taq-Polymerase, DNTPs from (Genet Bio) China,
RT enzyme kit from (Thermo scientiﬁc, USA) and other molecular
grade chemicals from Merck Bangalore, India. All other chemicals
were of analar grade obtained from Sisco research Laboratory,
Bombay, India.
2.3. Experimental design
2.3.1. Aspartame dose
The European Food Safety Authority recently conﬁrmed its daily
acceptable intake (ADI) for aspartame of 40 mg/kg b.wt./day.
Aspartame mixed in sterile saline was administered orally (40 mg/
kg body weight) for 90 days and this dosage was based on the FDA
approved Daily acceptable intake (ADI) limit.
2.3.2. Groups
The rats were divided into three groups, namely, saline control,
MTX-treated control, and MTX-treated aspartame administered
groups. Each group consisted of six animals. One separate set of
animals were employed for behavioral studies. One set of animals
was used for biochemical assays. One set of animals were used to
study the gene and protein expression, One set of animals were
used to study the histology and immunohistochemistry.MTX in
sterile saline was administered (0.2 mg/kg/day) subcutaneously for
7 days to induce folate deﬁciency in MTX controls as well as to
MTX þ aspartame treated groups [32]. One week after treatment
with MTX, folate deﬁciency was conﬁrmed by estimating the uri-
nary excretion of formaminoglutamic acid (FIGLU) [33]. From the
eighth day, the MTX-treated aspartame group received the oral
intubation of aspartame, whereas the other two groups received
equivalent volumes of saline as an oral dose and all animals were
handled similarly. The chronic dose of aspartame was given for 90
days and all the animals were fed folate-deﬁcient diet except the
control animals till 90 days.
2.4. Sample collections
The animals were sacriﬁced using higher dose of long acting
pentothal sodium (100 mg/kg.b.wt). The blood samples and isola-
tion of brain was performed between 8 and 10 a.m. to avoid
circadian rhythm induced changes. The brain was immediately
removed and washed with ice-cold phosphate buffered saline
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discrete regions of brain (cerebral cortex, cerebellum, midbrain,
pons medulla, hippocampus and hypothalamus) were dissected
according the method given by Glowinski and Iverson [34]. The
homogenate (10%w/v) of the individual regions were prepared in a
Teﬂon-glass tissue homogenizer, using ice-cold PBS (100 mm, pH
7.4) buffer and centrifuged separately in refrigerated centrifuge at
3000 rpm for 15 min. The supernatant was used for analyzing the
parameters in this study. For RNA isolation and protein isolation
separate group of animals were used by appropriate methods. For
immunohistochemical analysis separate set of animals were used
for perfusion and brain dissection.
2.5. Estimation of formate level
100 mL plasma was deproteinized with equal volume of aceto-
nitrile and centrifuged for 7 min at 4 C [35]. The supernatant
(20 mL) was analysed for blood formate using a HPLC refractive
index detector system (Shimadzu RID, Japan) (equipped with Rezex
ROA-organic acid column 300 mm  7.5 mm I.D., Phenomenex)
with the security guard cartridge (AJO 4490 Phenomenex). Column
oven was used to maintain the temperature at 60 C. The mobile
phase was 0.026 N sulphuric acid [36]. By using formate as an
external standard, the recovery of formate (HPLC grade) from blood
was found to be 92%. The detector sensitivity for formatewas found
to be 5 mg/100 mL and reproducibility was >90%.
2.6. Hydrogen peroxide
The hydrogen peroxide generation was assayed by the method
of Pick and Keisari [37]. Horse radish peroxidase converts hydrogen
peroxide into water and oxygen. This causes oxidation of phenol
red which forms adduct with dextrose which has maximum
absorbance at 610 nm. The hydrogen peroxide generated was
expressed as mM of H2O2 generated/mg protein.
2.7. Emotional and locomotion status of animals open ﬁeld
behavior (OFB)
Open ﬁeld behavior was a simple test to evaluate the locomotion
and emotional status of the animals. The apparatus usedwas a large
rectangular box (100 l00 cm) made of 40 cm high plywood walls.
The ﬂoor consisted of a clean dark plastic material with a grid
painted in white dividing the ﬁeld into 25 (5 5) equal squares.
Illuminationwas provided by a 60W bulb placed 100 cm above the
center of the ﬁeld. A weak cider vinegar solution (10%) was used to
clean the apparatus prior to the introduction of each animal. Rat
was placed in one corner of the apparatus and its behavior was
observed for 5 min [38]. In order to eliminate bias three persons
were recording the scores.
2.8. Evaluation of anxiety state of rats by elevated plus maze (EPM)
This test was based on the natural aversion of rodents for open
spaces and heights. . The elevated plus maze was made of wooden
Perspex, with two opposite open arms (50  10 cm) and two
opposite closed arms of the same size and 50 cm high walls [39].
The arms were connected by a central square (10  10 cm). In
addition, because the ﬂoor surface of the maze was smooth,
wooden ridges bordering the open arms (0.5 cm) were added to
provide additional grip for the animals. The entire apparatus was
elevated 50 cm above a white ﬂoor. The apparatus was situated in a
darkened room, illuminated by a single 60 W white light bulb
located approximately 50 cm above from the centre of the maze.
Rats were tested for 5 min in an EPM to ensure in anxiety levels andwere placed in the central square of the maze, facing one of the
open arm, observer seated approximately 1 m from the apparatus.
The number of entries and time spent in each arm were scored for
the ﬁrst 5 min. Arm entries were counted only when all four paws
had entered either a closed or an open arm.
The number of head dips and fecal bolus were also recorded. At
the end of the test, each rat was returned to its home cage. A weak
cider vinegar solution (10%) was used to clean the apparatus prior
to the introduction of each animal. Each animal was exposed to
EPM test only once.
2.9. Isolation of total RNA & reverse transcription-polymerized
chain reaction (RT-PCR)
Total RNA was isolated from cells using Trizol reagent following
the method of Chomczynski and Sacchi [40]. The total RNA ob-
tained was free from protein and DNA contamination. The reverse
transcription step was performed by using the RT enzyme kit. Each
20 mL reaction mixture contained 5 mL OligodT (10 mM), 1 mL dNTP
(10 mM), 4 mL First Strand buffer (5x), 1 mL DTT (0.1 M), 0.2 mL super
script III reverse transcriptase (200 U/mL) varied quantity of RNA
template (dependent on RNA concentration) and RNase free water
to make up the volume. Thermal cycling conditions for ﬁrst strand
reaction consisted of 25 C for 5 min, 50 C for 45 min, 70 C for
15 min and ﬁnally maintained at 4 C for 5 min. PCR ampliﬁcation
was performed using Taq DNA Polymerase. Each 20 mL of sample
contained 10 mL Master mix (2 mM), 1 mL forward primer, 1 mL
reverse primer for both gene of interest and internal control
consecutively, 2 mL RT sample, 4 mL sterile water. The mixture was
kept at thermocycler and ampliﬁed for 35 cycles. Each thermocy-
cling consisted of 94 C for 30 s, varied annealing temperature for
each gene of interest for 30 s, 72 C for 30 s b-actin gene was co
ampliﬁed with gene using the same procedures. The sense and
antisense primer for the study is tabulated in Table 1. Ten microli-
ters of each PCR product was analyzed by gel electrophoresis on 2%
agarose gel.
Agarose gel electrophoresis is an effective method for the
identiﬁcation of puriﬁed DNA molecules [41]. Ampliﬁed product
was analyzed by agarose gel electrophoresis with ethidium bro-
mide staining. Then the gel containing cDNA was visualized with
the help of ﬂuorescent imager (Bio-Rad, USA).The Band intensity
was quantiﬁed by Quantity One Software. The band intensiﬁcation
for each enzyme mRNA was normalized with that of the internal
control b-actin using Quantity One Software.
2.10. Immuno blotting
Tissue lysate was prepared with radio immuno assay buffer
(RIPA) (Sigma) and protease inhibitor [42]. Equal amounts of pro-
tein (60 mg) were electrophoresed on 10% SDS-PAGE. Following
electrophoresis, separated proteins on SDS-PAGE gels were trans-
ferred on PVDF membrane (Millipore, USA). To block the nonspe-
ciﬁc binding, the membranes were incubated blocking buffer with
5% skimmed milk for 2 h. Membranes were probed with primary
antibodies (Biovision and Pierce,USA). Blots were incubated with
horseradish peroxidase-conjugated secondary antibodies
(1:10,000) (Merck). The bands were developed using ECL kit (Mil-
lipore, USA) in Chemi Doc image scanner from Bio-Rad. The band
intensity was quantiﬁed by Quantity One software (Bio-Rad, USA).
The membranes were stripped and reprobed for B-actin (Sigma)
(1:5000) as an internal control.
2.11. Immunohistochemical analysis
Animals were deeply anesthetized with ketamine
Table 1
The sense and antisense primer sequences of the gene of interest for PCR ampliﬁcation.
Gene Sequence Ampliﬁed product (bp) Annealing temp/Cycles
TNF-a Sense: CTCCCAGAAAAGCAAGCAAC 210 55 C/35
Antisense: CGAGCAGGAATGAGAAGAGG
Fas Sense: TGCACCAACCTGCCATCCGT 139 55 C/35
Antisense: ATTCTGGGTCCGGGTGCAGT
Casp8 Sense: GCGACAGGTTACAGCTCTCC 180 55 C/35
Antisense: GCAGCCTCTGAAATAGCACC
Casp9 Sense: CTGGCCCAGTGTGAATACCT 233 55 C/35
Antisense: CTCAGTCAACTCCTGGGCTC
JNK3 Sense: AACAATCGCTACACCTCCAAAGAC 330 56 C/35
Antisense: GGCAATAGATGACACATCCACG
b-actin Sense: TCATGCCATCCTGCGTCTGGACCT 598 55 C/35
Antisense: CGGACTCATCGTACTCCTGCTTG
Fig. 1. Effect of Aspartame (40 mg/kg b.w) on plasma formate level (mM) in rat by
HPLC.
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phosphate-buffered saline, followed by buffered 10% para-
formaldehyde. The brain, was removed, and preserved in para-
formaldehyde at 4 C until processed for immunohistochemistry.
Then kept on runningwater to remove paraformaldehyde pigments
and dehydrated with ascending grades of alcohol. After impreg-
nationwith parafﬁnwax, the parafﬁn blocks weremade. They were
processed and sections were cut with 10 mm in thickness using
“Spencer Lens, rotatory microtome (no 820, New york, USA).
Immunohistochemical analysis was carried out using the DAB
universal staining kit (Merck Genie, Bengaluru, India). The sections
were deparafﬁnized in xylene and dehydrated in ethanol. After
washing with PBS, slides were incubated with 3% H2O2 in at room
temperature for 15 min to quench endogenous peroxidase activity.
After antigen retrieval (15 min of heating at 95 C in 10 mM citrate
buffer, pH 6.0), the slides were incubated with blocking solution
(10% normal goat serum) for 5 min at room temperature. Then, the
sections were incubated overnight with primary antibody. Subse-
quently, the sections were incubated with HRP secondary link
antibody for 30 min at room temperature, washed with PBS. Then,
the sections were treated with DAB chromogen for 15 min. Finally,
the sections were washed with deionised water, counter stained
with haematoxylin and mounted. Photographs were taken using
Nikon microscope (Nikon Japan DS-Fi1).2.12. Statistical analysis
Statistical analysis was carried out using the SPSS statistical
package version 17.0. The results are expressed as Mean ± SD and
the data were analyzed by the one-way analysis of variance
(ANOVA) followed by Turkey's multiple comparison tests when
there is a signiﬁcant ‘F’ test ratio. The level of signiﬁcance was ﬁxed
at p  0.05.3. Results
The data from various groups for the individual parameters are
presented as bar diagram with Mean ± SD.3.1. Plasma formate level
The data from various groups are presented as bar diagramwith
mean ± SD (Fig. 1). The formate level in the MTX treated control
animals did not signiﬁcantly differ from the saline controls. How-
ever, the aspartame treated MTX animals showed a marked in-
crease in the plasma formate level from control and MTX treated
control animals. The control as well as MTX treated animals
showed no signiﬁcant variation.3.2. Hydrogen peroxide
The results are given in Fig. 2. The hydrogenperoxide level in the
MTX treated animals did not signiﬁcantly differ from the controls.
However, the aspartame treated MTX animals showed a marked
increase in the hydrogen peroxide level in brain region (cerebral
cortex, cerebellum, hippocampus, hypothalamus, midbrain, pons
medulla) from control and MTX treated animals.
3.3. Effect of aspartame in locoemotor activity and emotionality
behavior in open ﬁeld
All the animals appeared healthy and no mortality was
observed. The effect of aspartame on locoemotor activity and
emotionality behavior by open ﬁeld are given in Table 2. The
locoemotor activity and emotionality behavior in the MTX treated
animals did not signiﬁcantly differ from the controls. However, the
aspartame treated MTX animals showed a marked increase in the
immobilization, fecal bolus and marked decrease in ambulation
(peripheral square), ambulation (central Square), Rearing, groom-
ing from the control as well as from the MTX treated animals.
3.4. Effect of aspartame in anxiety behavior by elevated plus maze
The effect of aspartame on anxiety behavior by elevated plus
maze are given in Table 3. The open arm entry in the MTX treated
animals did not signiﬁcantly differ from the controls. However, the
aspartame treated MTX animals showed a marked decrease in
number of open arm entry and percentage of open arm entry from
Fig. 2. Effect of Aspartame (40 mg/kg b.w) on Hydrogen peroxide radical levels (m moles of H2O2 generated/mg protein) in rat brain discrete regions. Legends for the ﬁgure: CC-
Cerebral cortex, CB-Cerebellum, MB-Midbrain, PM-Ponsmedulla, HP-Hippocampus,HY-Hypothalamus. Comparison and analysis were done by the one-way analysis of variance
(ANOVA), (n ¼ 6) control group was compared with MTX control group and aspartame MTX group, MTX control group was compared with Aspartame MTX group. Control, MTX
control- Methotrexate treated group, Asp þ MTX- Aspartame þ Methotrexate treated group. The data from various groups for the individual parameters are presented as bar
diagram with mean ± SD. signiﬁcance ﬁxed at P < 0.05, Aspartame treated group when compared to control signiﬁcance is marked as * and MTX treated groups signiﬁcance is
marked as #.
Table 2
Effect of aspartame on Open ﬁeld behavior.
Open ﬁeld behavior (OFB) Control MTX control Aspartame þ MTX (90 days)
Ambulation (peripheral square) 61.0 ± 13.14 60.83 ± 9.36 26.33 ± 6.88a,b
Ambulation (central square) 7.33 ± 2.16 7.16 ± 1.47 2.5 ± 1.04a,b
Rearing 22.0 ± 4.28 22.33 ± 3.98 13.3 ± 4.41a,b
Grooming 21.83 ± 3.76 19.83 ± 4.35 11.33 ± 2.58a,b
Immobilization 28.16 ± 5.26 29.66 ± 8.14 51.50 ± 12.43a,b
Fecal 2.0 ± 0.89 1.83 ± 0.75 3.50 ± 1.04a,b
Data are expressed as Mean ± SD and signiﬁcance at p < 0.05.
a Signiﬁcant compared to control.
b Signiﬁcant compared to MTX control.
Table 3
Effect of aspartame on Elevated plus maze.
Elevated plus maze (EPM) Control MTX control Aspartame þ MTX (90 days)
Open arm entry 5.0 ± 0.89 4.50 ± 0.54 2.16 ± 0.75a,b
Percentage of open arm entry 46.96 ± 8.46 46.81 ± 5.33 16.86 ± 4.99a,b
Time spend in open arm entry 49.66 ± 10.68 47.33 ± 7.44 19.33 ± 5.71a,b
% of time spend in open arm 24.69 ± 5.56 22.44 ± 3.54 8.30 ± 5.61a,b
Head dips 23.16 ± 6.08 20.50 ± 5.12 52.33 ± 12.62a,b
Fecal bolus 1.66 ± 0.51 1.33 ± 0.81 3.0 ± 0.89a,b
Data are expressed as Mean ± SD and signiﬁcance at p < 0.05.
a Signiﬁcant compared to control.
b Signiﬁcant compared to MTX control.
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The results of time spent in open arm are given in Table 3. The
time spent in the open arm in the MTX treated animals did not
signiﬁcantly differ from the controls. However, the aspartame
treated MTX animals showed a marked decrease in time spent in
open arm and percentage of time spent in open arm from the
control as well as from the MTX treated animals.
The results are given in Table 3. The number of head dips and
fecal bolus observed in the MTX treated control animals did not
signiﬁcantly differ from the controls. However, the aspartame
treated MTX animals showed a marked increase in number of head
dips and fecal bolus from the control as well as from the MTX
treated animals.
3.5. mRNA expressions
The results are given in Figs. 3 and 4. Using b-actin as an internal
control the fas, TNFa, JNK3, Caspase8 and 9 gene expression was
studied. The fas, TNFa, JNK3, Caspase8 and 9 gene expression in the
MTX control animals did not signiﬁcantly (p < 0.05) differ from thecontrols. However, the aspartame treated MTX animals showed a
marked increase in the fas, TNFa, JNK3, Caspase8 and 9 gene ex-
pressions in the respective brain region from control and MTX
control animals indicating the enhancement of neuronal cell death.
3.6. Protein expression
The results are given in Fig. 5. Using b-actin as an internal
control the fas, JNK3 and Caspase 9 protein expressionwas studied.
The fas, JNK3 and Caspase 9 protein expression in the MTX control
animals did not signiﬁcantly (p < 0.05) differ from the controls.
However, the aspartame treated MTX animals showed a marked
increase in the fas, JNK3 and Caspase 9 protein expression in the
respective brain region from control and MTX control animals
indicating the enhancement of neuronal cell death.
3.7. Immunohistochemistry
The results are given in Fig. 6. The photomicrograph shows a
signiﬁcant amount of neurons undergone brown coloured reaction
Fig. 3. Effect of long term aspartame on fas and caspase 9 mRNA expression in brain regions of Wistar albino rats. Lane-1,4,7,10 e Control, Lane-2,5,8,11 eMTX control, Lane-3,6,9,12
e MTX þ Aspartame, M e Marker. Lane-1,2,3 e Cerebral cortex, Lane-4,5,6 e Cerebellum, Lane-7,8,9 e Hippocampus, Lane-10,11,12 e Hypothalamus.
Fig. 4. Effect of long term aspartame on TNFa, JNK3 and Caspase 8 mRNA expression in brain regions of Wistar albino rats. Lane-1,4,7,10 e Control, Lane-2,5,8,11 e MTX control,
Lane-3,6,9,12 e MTX þ Aspartame, M e Marker. Lane-1,2,3 e Cerebral cortex, Lane-4,5,6 e Cerebellum, Lane-7,8,9 e Hippocampus, Lane-10,11,12 e Hypothalamus.
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Caspase 9 and Caspase 8 protein expression in the brain. Aspartame
treated animals brain region showed a marked signiﬁcant increase
in the brown coloured positive cells in the prefrontal cortex when
compared to the control and MTX control brain. The overall results
indicate that aspartame is effective in bringing about changes at
cellular level.4. Discussion
Aspartame represents 62% of the value of the intense sweetener
market in terms of its world consumption [43]. Upon ingestion,
aspartame is immediately absorbed from the intestinal lumen and
metabolized to phenylalanine, aspartic acid and methanol [44].
This present study aim in determining deleterious effect of the toxic
Fig. 5. Effect of long term aspartame on Caspase-9, JNK 3 and Fas protein expression in brain regions of Wistar albino rats. Lane-1,4,7 e Control, Lane-2,5,8 e MTX, Lane-3,6,9 e
MTX þ Aspartame. Lane-1,2,3 e Cerebral cortex, Lane-4,5,6 e Cerebellum, Lane-7,8,9 e Hippocampus.
Fig. 6. Effect of long term aspartame on Caspase-9 and caspase 8 protein expression in brain prefrontal cortex of Wistar albino rats. Immuno histomicrograph staining of brain in
Control, Methotrexate (MTX) control and Aspartame þ Methotrexate treated animals.
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aspartame. Earlier studies on chronic aspartame exposure (75 mg/
kg) showed and increase levels of methanol in aspartame treated
when compared to control and MTX treated alone which is a clear
indication of increased methanol level [14]. As already reported
that the metabolic fate of methanol is the direct oxidation to
formaldehyde and then into formate, the absorption-metabolism
sequence of methanol-formaldehyde-formic acid also results in
synergistic damage [45].
The severity of clinical ﬁndings in methanol intoxicationcorrelated better with formate levels [46]. In this present study
(40 mg/kg) for 90 days aspartame exposure we aim to evaluate the
formate level and our ﬁnding shows an increased formate level in
aspartame treated animals whichmay be an indicative for oxidative
damage caused by aspartame metabolites [68e70]. The accumu-
lation of formate rather than methanol is itself considered to cause
methanol toxicity [47].
It is relevant to point out that in the earlier report on aspartame
there was marked increase in the corticosteroid level in the plasma
for (75 mg/kg) [14] which indicate that the dietary sweetener
I. Ashok et al. / Journal of Nutrition & Intermediary Metabolism 2 (2015) 76e85 83aspartame could act as a chemical stressor. McIntosh et al. [48]
reported a decreased activity of the antioxidant enzymes in the
brain of rats treated with glucocorticoids. Ashok and Sheeladevi
[14], observed alterations in the free-radical-scavenging system
which could have let to the accumulation of free radicals. SOD
converts superoxide anion (O2) to hydrogen peroxide (H2O2) [49],
which are subsequently converted to water and molecular oxygen
by glutathione peroxidase or catalase [50] and accumulation of
superoxide anion (O2) to hydrogen peroxide (H2O2) in the
aspartame treated alone when compared to that of control and
MTX treated alone may be an indicative of altered antioxidant
enzyme activity. H2O2 is a strong oxidant and diffuses easily across
membranes, although the diffusion rate is dependent on the con-
centration gradient across the membrane. Lipid per oxidation re-
sults in the degradation of lipids via a free radical chain reaction
and the reaction may be initiated by H2O2, Hence, the increase in
H2O2 in this study after aspartame ingestion may be a contributing
factor for the alteration Moreover, this increase in H2O2 after
aspartame consumption could not be overlooked as [51] stated that
prolonged exposure to free radicals, even at a low concentration,
may result in the damage of biologically important molecules and
the cells can be injured or killed when the ROS generation over-
whelms the cellular antioxidant capacity [52].
4.1. Aspartame exposure on behaviour
It has been reported that consumption of aspartame could cause
neurological and behavioural disturbances in sensitive individuals
[4]. Behaviour can be both an event and a process and observable
behaviors are the result of the integration of all of the processes
ongoing in underlying organ systems, in interaction with the
external social and physical environment. Open-ﬁeld behavior is
thought to reﬂect emotional reactivity and exploratory behavior
[53]. The locoemotor activity and emotionality behavior in the
MTX treated animals did not signiﬁcantly differ from the controls.
However the marked increased in the immobilization, fecal bolus
and marked decrease in ambulation (peripheral square), ambula-
tion (central Square), Rearing, grooming were observed in the
aspartame treated MTX group which indicated the fearfulness.
Motor deﬁcits is manifested by decrease line crossing, rearing and
grooming activities [54] whereas Defecation pellets are commonly
used as a sign of fear since emotional subjects are likely to defe-
cation mildly stressful situation, resulting from the emotional-
induced parasympathetic activity [55] Normally, hyperactivity is
observed only when the open ﬁeld is novel to the animals, and
disappears when the testing cage has become familiar [56] This test
clearly shows that the Aspartame treated MTX did not get accli-
matized to the open-ﬁeld environment even after repeated expo-
sures to it and, hence, can be categorized as highly emotional
animals andmotor deﬁcit. The elevated plus-maze is an anxiety test
based on the exploration of an unfamiliar open environment.
Indeed, the elevated plus-maze is one of the most popular models
currently used in the study of animal anxiety [57]. In the present
study, exposure to aspartame (40 mg/kg bw) precipitated anxiety
and defensive behavior in rats, we observed decreased time spent
and number and percentage of entries in the open arm in the
aspartame treated animals when compared to control and MTX
treated animals. Accordingly the number of head dips observed in
the MTX treated control animals did not signiﬁcantly differ from
the controls. However, the aspartame treated MTX animals showed
a marked increase in number of head dips from the control as well
as from the MTX treated animals and head dipping activity is
directly related to anxiety [58]. This is in agreement with Ashok
et al. [18], who reported that long-term basis of aspartame con-
sumption (75 mg/kg b.wt.) may affect the brain and it may be dueto its metabolite methanol or aspartame may have acted as a
chemical stressor to alter the brain behavior pattern in rats.
4.2. Aspartame exposure on apoptosis
Extrinsic apoptosis, which is triggered by the extracellular sig-
nals that activate the death receptor family, is distinguished from
intrinsic apoptosis, which is induced by intracellular signals such as
DNA damage, oxidative stress, and nutrient deprivation [59].
Numerous reports and various issues, concerning the toxic effects
of aspartame have continued to be raised. It has been implicated
revealing high incidence of brain tumors in aspartame-fed rats
compared to no brain tumors in concurrent control [60]. Mean-
while, several experimental studies suggested that, astrocytomas
were the exact kind of brain tumor found in aspartame dosed rats
[61].These free radicals has been shown to damage cellular proteins
and DNA. The most immediate DNA damage was to the mito-
chondrial DNA [62]. Free radicals had been shown to prevent up-
take of excitotoxins by astrocytes as well, which would signiﬁcantly
increase extra cellular aspartame metabolites levels. This created a
vicious cycle that would multiply any resulting damage and mal-
functioning of neurophysiologic system [63]. It was also added that,
aspartame metabolites induced amino acids imbalance within
neuron micro environment, thus producing ultimate damage [64].
Receptor dependent pathway is activated when death ligands, such
as Fas ligand or TNF-a, bind to their receptors at the plasma
membrane. This results in homotrimerization of the receptor and
recruitment of speciﬁc adaptor proteins, such as Fas-associated
death domain (FADD) and procaspase- 8, into a death-inducing
signaling complex. This in turn, leads to activation of initiator
caspase-8 and subsequently activates effector caspases [65]. Dys-
regulation of TNF production has been implicated in a variety of
human diseases including cancer. Another key regulator of
apoptotic pathway is the Fas system. Fas is a type I transmembrane
receptor protein. The ligation of FasL to Fas triggers, FasL mediated
apoptotic death in a target cell leading to the activation of caspase3
[66]. The apoptotic process is also affected by many other signaling
pathways, especially activation via ROS in TNF- a-mediated JNK c-
Jun N-terminal kinases (JNK) (stress activated protein kinases)
which has been consistently demonstrated in various cellular sys-
tems [21]. JNK3 is found to be neural speciﬁc [67]. The sweetener
could also increase brain TNF-a, a potent pro-inﬂammatory cyto-
kine that is produced by glial cells involved in various physio-
pathological conditions in the CNS. Pro-inﬂammatory cytokines are
important mediators of inﬂammation and injury and are known
contributors to excitotoxic neuronal damage. This damagemight be
due to the oxidative stress in the brain, induced by methanol from
aspartame. This is in agreement with our previous reports which
suggest that aspartame administration at a dose level of 40 mg/kg
may induce an oxidative stress [68e70].
The gene expressions of extrinsic regulated apoptotic genes like,
TNFa, Fas, JNK3, Caspase8 and 9 were estimated to detect whether
aspartame induces apoptosis via extrinsic pathway. The gene
expression of TNFa, Fas, JNK3, Caspase8 and 9 were increased in
aspartame þMTX group supplemented group compared to control
and MTX alone group conﬁrming that aspartame exposure can
induce apoptosis in cerebral cortex, cerebellum, hippocampus and
hypothalamus via extrinsic pathway.
The protein expressions of Fas, JNK3 and Caspase 9 protein
expression were studied. The Fas, JNK3 and Caspase 9 protein
expression in the MTX control animals did not signiﬁcantly differ
from the controls. However, the aspartame treated MTX animals
showed a marked increase in the fas, JNK3 and Caspase 9 protein
expression in the respective brain region from control and MTX
control animals indicating the enhancement of neuronal cell death.
I. Ashok et al. / Journal of Nutrition & Intermediary Metabolism 2 (2015) 76e8584This present study reveals that aspartame administration in the
body system could induce neurobehavioural changes and extrinsic
apoptotic expression in the brain. The observed changes may be
due to the methanol or its metabolite. Since there is an ever
increasing consumption of aspartame in modern society with re-
gard to its toxic nature it is essential to create awareness regarding
the usage of this artiﬁcial sweetener.
5. Conclusion
The present study reveals that aspartame administration alters
the functional activity in the brain by probably elevating the free
radical levels. The observed changes may owe to the methanol for
the generation of free radicals in the brain regions. Moreover the
long term FDA approved daily acceptable intake (40 mg/kg b.wt)
aspartame administration distorted the brain function and gener-
ated apoptosis in brain regions. Since aspartame consumption is on
the rise among common people, it is essential to create awareness
regarding the usage of this artiﬁcial sweetener. Further studies are
required to evaluate the effect of aspartame in depth in the future.
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